Immunosuppressive agents in childhood nephrotic syndrome: A meta-analysis of randomized controlled trials

Kidney International

Volumn 59, Issue 5, 2001, Pages 1919-1927

  Durkan, Anne M ^a,b   Hodson, Elisabeth M ^a,b   Willis, Narelle S ^a,b   Craig, Jonathan C ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Azathioprine; Chlorambucil; Cyclophosphamide; Cyclosporine; Levamisole; Meta analysis; Prednisone; Steroid sensitive nephrotic syndrome

Indexed keywords

CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LEVAMISOLE; PREDNISONE;

ARTICLE; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; HUMAN; MEDICAL LITERATURE; META ANALYSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; TREATMENT OUTCOME;

EID: 0035053715     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590051919.x     Document Type: Article

References (42)

1. The nephrotic syndrome: Its incidence and implications for the community
2. Long-term outcome of primary nephrotic syndrome
3. Prognostic significance of the early course of minimal change nephrotic syndrome: Report of the International Study of Kidney Disease in Children
4. Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence
5. Cytotoxic drugs in steroid-resistant renal disease: Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children
6. Sterility and testicular atrophy related to cyclophosphamide therapy
7. Cyclophosphamide therapy and sterility
8. Cyclophosphamide and the pubertal testis
9. Controlled trial of azathioprine in children with nephrotic syndrome
10. Chailing tang in the treatment of steroid-dependent nephrosis syndrome
11. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicentre randomized controlled trial
12. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood
13. Controlled trial of disodium cromoglycate in prevention of relapse of steroid-responsive nephrotic syndrome of childhood
14. Intravenous immunoglobulin in minimal change nephrotic syndrome: A crossover trial
15. Management of minimal lesion glomerulonephritis: Evidence-based recommendations
16. The treatment of minimal change nephrotic syndrome: Lessons learned from multicentre co-operative studies
17. Consensus statement on management and audit potential for steroid responsive nephrotic syndrome: Report of a Workshop by the British Association for Paediatric Nephrology and Research Unit, Royal College of Physicians
18. Identifying relevant studies for systematic reviews
19. Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome: Report of the International of Kidney Disease in Children
20. A controlled prospective study of cyclophosphamide in relapsing, corticosteroid-responsive, minimal-lesion nephrotic syndrome in childhood
21. Controlled trial of cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood
22. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children
23. Levamisole in the treatment of steroid dependent or frequent relapsing nephrotic syndrome in children
24. Controlled trial of azathioprine in treatment of steroid-responsive nephrotic syndrome of childhood
25. Controlled trial of chlorambucil in frequently relapsing nephrotic syndrome in children (a preliminary report)
26. Chlorambucil treatment of frequently relapsing nephrotic syndrome
27. Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood
28. Eight and 12 week courses of cyclophosphamide in nephrotic syndrome
29. Therapeutic and toxic effects observed with different dosage programs of cyclophosphamide in treatment of steroid-responsive but frequently relapsing nephrotic syndrome
30. Chlorambucil dosage in frequently relapsing nephrotic syndrome: A controlled clinical trial
31. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: A multicentre randomized controlled trial
32. Long-term cyclosporin A treatment of minimal-change nephrotic syndrome of childhood
33. Cyclosporin in the treatment of idiopathic nephrotic syndrome in children
34. Cyclophosphamide treatment of steroid dependent nephrotic syndrome: Comparison of eight week with 12 week course: Report of Arbeitsgemeinschaft fur Padiatrische Nephrologie
35. Randomized versus historical controls for clinical trials
36. An evidence based approach to individualising treatment
37. Empirical evidence of bias: Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
38. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?
39. Side effects of levamisole in children with nephrosis
40. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome